These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 34281600

  • 1. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X, Li Y, Sun Y, Jia M, Xu X, Huo L, Song W, Yao Y, Wang X.
    Trials; 2021 Jul 19; 22(1):466. PubMed ID: 34281600
    [Abstract] [Full Text] [Related]

  • 2. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
    Shen Z, Chen T, Deng B, Fan M, Hua J, Zhang M, Wang X.
    J Altern Complement Med; 2020 Nov 19; 26(11):1055-1063. PubMed ID: 32716206
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao JN, Zhang Y, Lan X, Chen Y, Li J, Zhang P, Wu LQ, Jia ST, Liu Y, Xu FQ.
    Medicine (Baltimore); 2019 Aug 19; 98(31):e16539. PubMed ID: 31374015
    [Abstract] [Full Text] [Related]

  • 4. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y, Zhang J, Zhao Y, Mao J, Zhu L, Gao R, Wang X, Zhu M, Ma L, Zhao M, Zheng W.
    Trials; 2018 Oct 20; 19(1):577. PubMed ID: 30342551
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial.
    Huanjia G, Hairong C, Jieqin Z, Xingzhen D, Xue F, Weizhang Z, Bojun C.
    Trials; 2021 May 10; 22(1):336. PubMed ID: 33971940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Traditional Chinese medicine for stable angina pectoris via TCM pattern differentiation and TCM mechanism: study protocol of a randomized controlled trial.
    Zhang Z, Zhang F, Wang Y, Du Y, Zhang H, Kong D, Liu Y, Yang G.
    Trials; 2014 Oct 30; 15():422. PubMed ID: 25359307
    [Abstract] [Full Text] [Related]

  • 8. Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial.
    He H, Chen G, Gao J, Liu Y, Zhang C, Liu C, Li H, He Q, Li J, Wang J.
    Trials; 2018 Sep 21; 19(1):515. PubMed ID: 30241562
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
    Leng Y, Gao H, Fu X, Xie H, Hu Z, Zhu J, Liu X, Zhou X, Xie Z, Xie C.
    Medicine (Baltimore); 2020 Jan 21; 99(3):e18713. PubMed ID: 32011447
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of Danshen extract on lipoprotein-associated phospholipase A2 levels in patients with stable angina pectoris: study protocol for a randomized controlled trial - the DOLPHIN study.
    Chen AD, Wang CL, Qin Y, Tian L, Chen LB, Yuan XM, Ma LX, Wang YF, Sun JR, Wang HS, Dai N, DOLPHIN investigator group.
    Trials; 2017 Dec 20; 18(1):606. PubMed ID: 29262859
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
    Zhao AM, Qiu WR, Mao LJ, Ren JG, Xu L, Yao MJ, Bilinksi K, Chang D, Liu JX.
    Trials; 2018 May 10; 19(1):275. PubMed ID: 29747670
    [Abstract] [Full Text] [Related]

  • 14. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J, Wu Y, Gong X, Ma Y, Yu S, Gao J.
    Trials; 2019 Aug 07; 20(1):481. PubMed ID: 31391092
    [Abstract] [Full Text] [Related]

  • 15. [Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to liver-qi stagnation and spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial].
    Wang TF, Xue XL, Zhang YJ, Han P, Li Z, Wang WP, Xing JM, Wang QB, Tang Y, Li L, Wang JJ, Li GR, Ji SL, Wu LX, Zhao Y, Wu XY, Zhao RS.
    Zhong Xi Yi Jie He Xue Bao; 2011 May 07; 9(5):515-24. PubMed ID: 21565137
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, randomized, double-blind clinical study on Wufuxinnaoqing Soft Capsule () in treatment of chronic stable angina patients with blood stasis syndrome.
    Zhang ZF, Xu FQ, Liu HX, Wang FR, Zhao MJ, Sun LJ, Xu Y, Hu YZ.
    Chin J Integr Med; 2015 Aug 07; 21(8):571-8. PubMed ID: 25555593
    [Abstract] [Full Text] [Related]

  • 17. Danhong injection in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Wang PQ, Li DD, Dong W, Liu J, Yu YN, Shen CT, Chen QG, Chen BW, Chen YD, Wang Z.
    Trials; 2015 Oct 21; 16():474. PubMed ID: 26489511
    [Abstract] [Full Text] [Related]

  • 18. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.
    Wang Y, Zhang Y, Du Y, Yang Y, Wei J, Zhang N, Mao M, Du W, Liu P.
    Medicine (Baltimore); 2019 Nov 21; 98(44):e17753. PubMed ID: 31689832
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome.
    Guo J, Dai S, Ding Y, He H, Zhang H, Dan W, Qin K, Wang H, Li A, Meng P, Li S, He Q.
    Medicine (Baltimore); 2020 Aug 14; 99(33):e21593. PubMed ID: 32872012
    [Abstract] [Full Text] [Related]

  • 20. Exploring the therapeutic mechanism of Baduanjin in the treatment of elderly stable angina pectoris based on the gut microbiota-lipid metabolism spectrum: Study protocol for a randomized controlled trial.
    Jin X, Yang S, Lu J, Li Y, Zhao Y, Li D, Wang X, Liu L, Wu M.
    Front Public Health; 2022 Aug 14; 10():1027839. PubMed ID: 36388277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.